Scilex Retains Kasowitz LLP to Fortify Intellectual Property Defenses

Palo Alto, Friday, 2 January 2026.
Scilex Holding Company has appointed Kasowitz LLP to lead its IP strategy as of January 2, 2026. This signals a robust pivot toward aggressively defending its non-opioid pain assets, including ZTlido® and ELYXYB®, to safeguard long-term shareholder value.